Colitis Latest Advances

Mesalazine enteric-coated tablets combined with retention enema for symptom alleviation in mild to moderate E2-type active ulcerative colitis: A retrospective comparative cohort study.

Journal: Pakistan journal of pharmaceutical sciences

Published: September 08, 2026

Rapid growth of a giant inflammatory polyp mimicking rectal malignancy in well-controlled Crohn's colitis: a diagnostic and therapeutic challenge.

Journal: Proceedings (Baylor University. Medical Center)

Published: September 08, 2026

Idiopathic mesenteric phlebosclerosis colitis: a clinicopathological analysis of three cases

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology

Published: September 07, 2026

Evaluating embryo euploidy among patients diagnosed with inflammatory bowel disease undergoing in vitro fertilization.

Journal: Minerva obstetrics and gynecology

Published: September 07, 2026

Atypical cutaneous manifestations of inflammatory bowel disease: A case series.

Journal: JAAD case reports

Published: September 05, 2026

Corticosteroid exposure, tapering, and survival in immune-related colitis: a 10-year real-world melanoma cohort.

Journal: Immuno-oncology technology

Published: September 05, 2026

Effect of JAK inhibitors on extraintestinal manifestations and concurrent immune-mediated inflammatory diseases in patients with inflammatory bowel disease.

Journal: Journal of Crohn's & colitis

Published: September 05, 2026

Robotic Versus Laparoscopic Ileal Pouch-Anal Anastomosis for Ulcerative Colitis: A Systematic Review and Comparative Meta-Analysis.

Journal: Journal of laparoendoscopic & advanced surgical techniques. Part A

Published: September 04, 2026

Cyanidin-3-O-glucoside ameliorates DSS-induced colitis in mice by modulating the PI3K-Akt pathway and preserving intestinal barrier function.

Journal: Food & function

Published: September 04, 2026

Rosmarinic acid alleviates colitis and repairs mucus barrier damage in a gut microbiota-dependent manner.

Journal: Food & function

Published: September 03, 2026

Early Diagnosis of Upper Eyelid Pyoderma Gangrenosum Using the PARACELSUS Score and Tissue-Sparing Management With Adjunctive Hypochlorous Acid Therapy: A Case Report.

Journal: Ophthalmic plastic and reconstructive surgery

Published: September 02, 2026

Pharmacological properties and clinical efficacy of sphingosine 1-phosphate (S1P) receptor modulator, Etrasimod (Velsipity® 2 mg tablets)

Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica

Published: September 02, 2026

Colitis Latest Advances

Find the Latest Research About Colitis

Mesalazine enteric-coated tablets combined with retention enema for symptom alleviation in mild to moderate E2-type active ulcerative colitis: A retrospective comparative cohort study.

Mesalazine enteric-coated tablets combined with retention enema for symptom alleviation in mild to moderate E2-type active ulcerative colitis: A retrospective comparative cohort study.

Rapid growth of a giant inflammatory polyp mimicking rectal malignancy in well-controlled Crohn's colitis: a diagnostic and therapeutic challenge.

Rapid growth of a giant inflammatory polyp mimicking rectal malignancy in well-controlled Crohn's colitis: a diagnostic and therapeutic challenge.

Idiopathic mesenteric phlebosclerosis colitis: a clinicopathological analysis of three cases

Idiopathic mesenteric phlebosclerosis colitis: a clinicopathological analysis of three cases

Evaluating embryo euploidy among patients diagnosed with inflammatory bowel disease undergoing in vitro fertilization.

Evaluating embryo euploidy among patients diagnosed with inflammatory bowel disease undergoing in vitro fertilization.

Atypical cutaneous manifestations of inflammatory bowel disease: A case series.

Atypical cutaneous manifestations of inflammatory bowel disease: A case series.

Corticosteroid exposure, tapering, and survival in immune-related colitis: a 10-year real-world melanoma cohort.

Corticosteroid exposure, tapering, and survival in immune-related colitis: a 10-year real-world melanoma cohort.

Effect of JAK inhibitors on extraintestinal manifestations and concurrent immune-mediated inflammatory diseases in patients with inflammatory bowel disease.

Effect of JAK inhibitors on extraintestinal manifestations and concurrent immune-mediated inflammatory diseases in patients with inflammatory bowel disease.

Robotic Versus Laparoscopic Ileal Pouch-Anal Anastomosis for Ulcerative Colitis: A Systematic Review and Comparative Meta-Analysis.

Robotic Versus Laparoscopic Ileal Pouch-Anal Anastomosis for Ulcerative Colitis: A Systematic Review and Comparative Meta-Analysis.

Cyanidin-3-O-glucoside ameliorates DSS-induced colitis in mice by modulating the PI3K-Akt pathway and preserving intestinal barrier function.

Cyanidin-3-O-glucoside ameliorates DSS-induced colitis in mice by modulating the PI3K-Akt pathway and preserving intestinal barrier function.

Rosmarinic acid alleviates colitis and repairs mucus barrier damage in a gut microbiota-dependent manner.

Rosmarinic acid alleviates colitis and repairs mucus barrier damage in a gut microbiota-dependent manner.

Early Diagnosis of Upper Eyelid Pyoderma Gangrenosum Using the PARACELSUS Score and Tissue-Sparing Management With Adjunctive Hypochlorous Acid Therapy: A Case Report.

Early Diagnosis of Upper Eyelid Pyoderma Gangrenosum Using the PARACELSUS Score and Tissue-Sparing Management With Adjunctive Hypochlorous Acid Therapy: A Case Report.

Pharmacological properties and clinical efficacy of sphingosine 1-phosphate (S1P) receptor modulator, Etrasimod (Velsipity® 2 mg tablets)

Pharmacological properties and clinical efficacy of sphingosine 1-phosphate (S1P) receptor modulator, Etrasimod (Velsipity® 2 mg tablets)